Product Launch (Blog)

Jan, 21 2020

Drug Screening Market is Expected to Reach a Market Value of USD 19.03 billion by 2026

Drug Screening Market is forecasted to grow at 12.9% for 2019-2026 with factors such as drug testing violation and accuracy issue associated with breathalyzers will restrict the growth of the market in emerging economies.

Drug screening market has shown an exceptional penetration in developed economies of North America. Availability of government funds and increasing consumption of illicit drugs will boost the growth of the market.

Drug Screening Market Scenario

According to Data Bridge Market Research the drug screening market is witnessing a growth in developing economies in the forecast period of 2019-2026 due to factors such as increasing awareness regarding drug screening policy, expansion of government funds and growing initiatives for drug testing, rising alcohol and drug abuse will help in the growth of the market. on the other hand, introduction of oral fluid testing and availability of finger-print based drug screening will further create new opportunities for the growth of the market in the above mentioned forecast period.

Now the question is which are the other regions that drug screening market is targeting? Data Bridge Market Research has forecasted a large growth in Asia-Pacific drug screening market in the forecast period of 2019-2026. The Data bridge market research new reports highlight the major growth factors and opportunities in the drug screening market.

For more analysis on the drug screening market request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst?dbmr=global-drug-screening-market

New Drug Screening Market Development in 2019

  • In November 2019, Silver Lake acquired First Advantage from Symphony Technology Group (STG) a drug screening solution and fingerprinting company. This acquisition will reduce risk while provide solutions for drug screening also increases the product portfolio of the company across the globe.

Scope of the Drug Screening Market

Drug screening market is segmented on the basis of countries into U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Kuwait, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Peru, Brazil, Argentina and Rest of South America as part of South America.

  • All country based analysis of the drug screening market is further analyzed based on maximum granularity into further segmentation. On the basis of product & services, the market is segmented into equipment, rapid testing devices, laboratory services and consumables. Based on sample type, the market is segmented into urine, breath, saliva, hair, blood, skin and sweat. The end-users covered for the report are workplace & schools, criminal justice systems & law enforcement agencies, drug testing laboratories, drug treatment centers, hospitals, personal users, and pain management centers.
  • Drug Screening is a technique used to detect illegal drugs in urine, blood and other biological samples in hospitals, schools, post-accident and others. Drug screening can be observed at the time of some suspicious case or cause, generally before sports event or employment. Some of the illegal drugs are heroin, cocaine, cannabis and other drugs.

To know more about the study https://www.databridgemarketresearch.com/reports/global-drug-screening-market

Key Pointers Covered in the Drug Screening Market Industry Trends and Forecast to 2026

  • Market Size
  • Market New Sales Volumes
  • Market Replacement Sales Volumes
  • Market Installed Base
  • Market By Brands
  • Market Procedure Volumes
  • Market Product Price Analysis
  • Market Healthcare Outcomes
  • Market Cost of Care Analysis
  • Market Regulatory Framework and Changes
  • Market Prices and Reimbursement Analysis
  • Market Shares in Different Regions
  • Recent Developments for Market Competitors
  • Market Upcoming Applications
  • Market Innovators Study

Key Market Competitors Covered in the report

  • Siemens
  • Quest Diagnostics Incorporated.
  • Thermo Fisher Scientific, Inc.
  • Abbott
  • Laboratory Corporation of America Holdings.
  • F. Hoffmann-La Roche Ltd
  • bioMérieux SA
  • Drägerwerk AG & Co. KGaA,
  • Bio-Rad Laboratories Inc
  • Biomedical Diagnostics
  • CannAmm
  • MPD, Inc.
  • Danaher
  • STERIS.
  • Agilent Technologies
  • Shimadzu Medical Pvt. Ltd

Above are the key players covered in the report, to know about more and exhaustive list of drug screening companies’ contact us https://www.databridgemarketresearch.com/toc?dbmr=global-drug-screening-market

Research Methodology: Global Drug Screening Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
  • Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Related Reports

Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/

 


Client Testimonials